CA3244382A1 - PROCESS FOR THE PRODUCTION OF OLIGONUCLEIC ACID COMPOUNDS - Google Patents
PROCESS FOR THE PRODUCTION OF OLIGONUCLEIC ACID COMPOUNDSInfo
- Publication number
- CA3244382A1 CA3244382A1 CA3244382A CA3244382A CA3244382A1 CA 3244382 A1 CA3244382 A1 CA 3244382A1 CA 3244382 A CA3244382 A CA 3244382A CA 3244382 A CA3244382 A CA 3244382A CA 3244382 A1 CA3244382 A1 CA 3244382A1
- Authority
- CA
- Canada
- Prior art keywords
- compound
- formula
- nucleic acid
- solution containing
- solution
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6527—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having nitrogen and oxygen atoms as the only ring hetero atoms
- C07F9/6533—Six-membered rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H1/00—Processes for the preparation of sugar derivatives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
- C07H21/04—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids with deoxyribosyl as saccharide radical
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2021212132 | 2021-12-27 | ||
| JP2021-212132 | 2021-12-27 | ||
| PCT/JP2022/048385 WO2023127918A1 (ja) | 2021-12-27 | 2022-12-27 | オリゴ核酸化合物の製造方法 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA3244382A1 true CA3244382A1 (en) | 2025-02-26 |
Family
ID=86999200
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA3244382A Pending CA3244382A1 (en) | 2021-12-27 | 2022-12-27 | PROCESS FOR THE PRODUCTION OF OLIGONUCLEIC ACID COMPOUNDS |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20250066396A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4458833A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JPWO2023127918A1 (cg-RX-API-DMAC7.html) |
| KR (1) | KR20240129006A (cg-RX-API-DMAC7.html) |
| CN (1) | CN118488959A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2022424485A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3244382A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2023127918A1 (cg-RX-API-DMAC7.html) |
Family Cites Families (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE312834T1 (de) | 1989-12-20 | 2005-12-15 | Avi Biopharma Inc | Ungeladene, auf morpholin basierende polymere mit chiralen, phosphor enthaltenden brücken zwischen den untereinheiten |
| AU5752601A (en) | 2000-05-04 | 2001-11-12 | Avi Biopharma Inc | Splice-region antisense composition and method |
| ES2627917T3 (es) | 2004-06-28 | 2017-08-01 | The University Of Western Australia | Oligonucleótidos no codificantes para la inducción de la omisión exónica y métodos de uso de los mismos |
| US7790694B2 (en) | 2005-07-13 | 2010-09-07 | Avi Biopharma Inc. | Antisense antibacterial method and compound |
| MX2010004955A (es) | 2007-11-15 | 2010-06-30 | Avi Biopharma Inc | Metodo de sintesis de oligomeros de morfolina. |
| EP3133160B1 (en) | 2008-10-24 | 2018-12-12 | Sarepta Therapeutics, Inc. | Exon skipping compositions for dmd |
| SI2607484T1 (sl) | 2008-10-27 | 2016-11-30 | Biomarin Technologies B.V. | Metode in sredstva za učinkovito preskakovanje eksona 45 v pre-mRNA Duchennove mišične distrofije |
| HUE040445T2 (hu) | 2009-11-12 | 2019-03-28 | Univ Western Australia | Antiszensz molekulák és eljárások betegségek kezelésére |
| TWI541024B (zh) | 2010-09-01 | 2016-07-11 | 日本新藥股份有限公司 | 反義核酸 |
| CN103154009B (zh) * | 2010-09-30 | 2015-06-10 | 日本新药株式会社 | 吗啉基核酸衍生物 |
| CN108588073A (zh) | 2011-12-28 | 2018-09-28 | 日本新药株式会社 | 反义核酸 |
| IN2014DN06768A (cg-RX-API-DMAC7.html) | 2012-02-17 | 2015-05-22 | Ajinomoto Kk | |
| US10214555B2 (en) | 2012-11-14 | 2019-02-26 | Takeda Pharmaceutical Company Limitjed | Method for liquid-phase synthesis of nucleic acid |
| EP3760720A1 (en) | 2013-03-14 | 2021-01-06 | Sarepta Therapeutics, Inc. | Exon skipping compositions for treating muscular dystrophy |
| HK1220154A1 (zh) | 2013-03-15 | 2017-04-28 | Sarepta Therapeutics, Inc. | 改进的用於治疗肌营养不良的组合物 |
| JP6477464B2 (ja) * | 2013-05-24 | 2019-03-06 | 味の素株式会社 | モルフォリノオリゴヌクレオチドの製造方法 |
| BR112016020618B1 (pt) | 2014-03-12 | 2023-04-04 | Nippon Shinyaku Co., Ltd. | Oligômero antissentido, composição farmacêutica, e, uso de um oligômero antissentido |
| PT3159409T (pt) | 2014-06-17 | 2020-01-21 | Nippon Shinyaku Co Ltd | Ácido nucleico anti-sentido para utilização no tratamento da distrofia muscular de duchenne |
| HUE050061T2 (hu) | 2015-09-15 | 2020-12-28 | Nippon Shinyaku Co Ltd | Antiszensz nukleinsav |
| US11560401B2 (en) * | 2018-05-10 | 2023-01-24 | Nippon Shinyaku Co., Ltd. | Method for preparing oligonucleic acid compound |
| JP6770553B2 (ja) * | 2018-07-20 | 2020-10-14 | 藤本化学製品株式会社 | アルコキシフェニル誘導体、ヌクレオシド保護体およびヌクレオチド保護体、オリゴヌクレオチド製造方法、ならびに、置換基除去方法 |
| EP4059944A4 (en) * | 2019-11-13 | 2024-04-10 | Nippon Shinyaku Co., Ltd. | METHOD FOR PREPARING AN OLIGONUCLICE ACID COMPOUND |
| EP4059943A4 (en) * | 2019-11-13 | 2024-01-31 | Nippon Shinyaku Co., Ltd. | METHOD FOR PRODUCING OLIGONUCLEIC ACID COMPOUND |
| IL294271A (en) | 2019-12-26 | 2022-08-01 | Nippon Shinyaku Co Ltd | Antisense nucleic acid that induces skipping of exon 50 |
| PE20230237A1 (es) | 2020-02-28 | 2023-02-07 | Nippon Shinyaku Co Ltd | Acidos nucleicos antisentido que inducen la omision del exon 51 |
| CN117279926A (zh) * | 2021-04-28 | 2023-12-22 | 日本新药株式会社 | 低聚核酸化合物的制造方法 |
-
2022
- 2022-12-27 KR KR1020247025422A patent/KR20240129006A/ko active Pending
- 2022-12-27 CN CN202280086091.8A patent/CN118488959A/zh active Pending
- 2022-12-27 JP JP2023571077A patent/JPWO2023127918A1/ja active Pending
- 2022-12-27 EP EP22916140.1A patent/EP4458833A4/en active Pending
- 2022-12-27 AU AU2022424485A patent/AU2022424485A1/en active Pending
- 2022-12-27 US US18/723,577 patent/US20250066396A1/en active Pending
- 2022-12-27 WO PCT/JP2022/048385 patent/WO2023127918A1/ja not_active Ceased
- 2022-12-27 CA CA3244382A patent/CA3244382A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| EP4458833A4 (en) | 2025-12-31 |
| AU2022424485A1 (en) | 2024-07-11 |
| WO2023127918A1 (ja) | 2023-07-06 |
| CN118488959A (zh) | 2024-08-13 |
| EP4458833A1 (en) | 2024-11-06 |
| JPWO2023127918A1 (cg-RX-API-DMAC7.html) | 2023-07-06 |
| KR20240129006A (ko) | 2024-08-27 |
| US20250066396A1 (en) | 2025-02-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP3428287B1 (en) | Conformationally-preorganized, minipeg-containing gamma-peptide nucleic acids | |
| JP6554180B6 (ja) | Dnaコード化化合物ライブラリーの固相合成方法 | |
| KR102504759B1 (ko) | 포스포로디아미데이트 모르폴리노 올리고머의 제조 방법 | |
| CN112384520B (zh) | 寡核苷酸化合物的制造方法 | |
| KR102523522B1 (ko) | 포스포로디아미데이트 모르폴리노 올리고머의 제조 방법 | |
| CN111051289A (zh) | 被保护的l-肌肽衍生物、l-肌肽以及结晶性l-肌肽锌络合物的制造方法 | |
| KR102523527B1 (ko) | 포스포로디아미데이트 모르폴리노 올리고머의 제조 방법 | |
| JP2026063490A (ja) | シトシン型架橋型ヌクレオシドアミダイト結晶及びその製造方法 | |
| JP2025134950A (ja) | オリゴヌクレオチドを調製するための方法 | |
| EP4458833A1 (en) | Method for producing oligonucleic acid compound | |
| HK40113683A (en) | Method for producing oligonucleic acid compound | |
| HK40108064A (en) | Method for producing oligonucleic acid compound | |
| RU2787350C1 (ru) | Способ получения морфолиновых олигомеров | |
| Abdelbaky et al. | Synthesis of α-(R)-/γ-(S)-Dimethyl Substituted Peptide Nucleic Acid Submonomer Using Mitsunobu Reaction | |
| US20230235328A1 (en) | Novel morpholino oligonucleotide derivatives | |
| CN121362135A (zh) | 一种用于寡核苷酸制备的通用载体us ii的高效合成方法 | |
| CN121930115A (zh) | 一种碘普罗胺杂质d的制备方法 | |
| CN117229310A (zh) | 一种sting激动剂及其中间体的制备方法 | |
| CN122010821A (zh) | 一种阿达格拉西布中间体的合成方法 | |
| CN121426713A (zh) | 含胍基的多取代苯甲酸酯盐酸盐杂质及其应用 | |
| CN114728995A (zh) | 制备具有改善的活性的催化活性dna分子的方法及其用于治疗哮喘的方法中的用途 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A00 | Application filed |
Free format text: ST27 STATUS EVENT CODE: A-1-1-A10-A00-A102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: COMPLIANCE REQUIREMENTS DETERMINED MET Effective date: 20240829 |
|
| A15 | Pct application entered into the national or regional phase |
Free format text: ST27 STATUS EVENT CODE: A-1-1-A10-A15-X000 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: NATIONAL ENTRY REQUIREMENTS DETERMINED COMPLIANT Effective date: 20240829 |
|
| P18 | Priority claim added or amended |
Free format text: ST27 STATUS EVENT CODE: A-1-1-P10-P18-P105 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: PRIORITY CLAIM REQUIREMENTS DETERMINED COMPLIANT Effective date: 20240829 |
|
| MFA | Maintenance fee for application paid |
Free format text: FEE DESCRIPTION TEXT: MF (APPLICATION, 2ND ANNIV.) - STANDARD Year of fee payment: 2 |
|
| U00 | Fee paid |
Free format text: ST27 STATUS EVENT CODE: A-1-1-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED Effective date: 20241031 |
|
| U11 | Full renewal or maintenance fee paid |
Free format text: ST27 STATUS EVENT CODE: A-1-1-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT DETERMINED COMPLIANT Effective date: 20241127 Free format text: ST27 STATUS EVENT CODE: A-1-1-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL Effective date: 20241127 |
|
| W00 | Other event occurred |
Free format text: ST27 STATUS EVENT CODE: A-1-1-W10-W00-W100 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: LETTER SENT Effective date: 20250212 |
|
| Q12 | Application published |
Free format text: ST27 STATUS EVENT CODE: A-1-1-Q10-Q12-X000 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: APPLICATION PUBLISHED (OPEN TO PUBLIC INSPECTION) Effective date: 20250226 |
|
| MFA | Maintenance fee for application paid |
Free format text: FEE DESCRIPTION TEXT: MF (APPLICATION, 3RD ANNIV.) - STANDARD Year of fee payment: 3 |
|
| U00 | Fee paid |
Free format text: ST27 STATUS EVENT CODE: A-1-1-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED Effective date: 20251106 |
|
| U11 | Full renewal or maintenance fee paid |
Free format text: ST27 STATUS EVENT CODE: A-1-1-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL Effective date: 20251106 |
|
| D11 | Substantive examination requested |
Free format text: ST27 STATUS EVENT CODE: A-1-1-D10-D11-D117 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: REQUEST FOR EXAMINATION RECEIVED Effective date: 20260716 |
|
| W00 | Other event occurred |
Free format text: ST27 STATUS EVENT CODE: A-1-1-W10-W00-W111 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: CORRESPONDENT DETERMINED COMPLIANT Effective date: 20260716 |
|
| D00 | Search and/or examination requested or commenced |
Free format text: ST27 STATUS EVENT CODE: A-1-1-D10-D00-D118 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: REQUEST FOR EXAMINATION REQUIREMENTS DETERMINED COMPLIANT Effective date: 20260805 |
|
| D11 | Substantive examination requested |
Free format text: ST27 STATUS EVENT CODE: A-1-2-D10-D11-D155 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: ALL REQUIREMENTS FOR EXAMINATION DETERMINED COMPLIANT Effective date: 20260805 |
|
| W00 | Other event occurred |
Free format text: ST27 STATUS EVENT CODE: A-2-2-W10-W00-W100 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: LETTER SENT Effective date: 20260805 |